[Combined treatment of uterine cancer using preoperative intracavitary gamma therapy].

Low-fractionated intracavitary gamma-therapy from the AGAT-B installation was given to 212 patients as the initial component of combined treatment. The treatment was well tolerated and was followed by a partial regression of tumor. It did not interfere with surgical intervention nor did it involve an increase in postoperative complication incidence. Application of the procedure raises the effectiveness of combined treatment of uterine cancer.